Funds and ETFs Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Hong Kong S.E.
Equities
2196
CNE100001M79
Pharmaceuticals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13.06 HKD | -3.55% | -2.39% | -23.06% |
05-15 | Fosun Pharma Unit Fosun Health to Receive Capital Injection from Foshan Chanxi City Investment | MT |
05-15 | China Approves Clinical Trials For Breast Cancer Drugs | MT |
ETFs positioned on Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.37% | 4 M€ | -27.92% | ||
0.63% | 2 M€ | -13.00% | - | |
0.21% | 3 M€ | +9.08% | - | |
0.18% | 2 M€ | -14.14% | ||
0.16% | 4 M€ | -11.56% | ||
0.03% | 35 M€ | -5.85% | - | |
0.02% | 454 M€ | +9.82% | - | |
0.02% | 2,867 M€ | +11.13% | - | |
0.02% | 153 M€ | +9.25% | - | |
0.02% | 4 M€ | -4.41% | - | |
0.01% | 32 M€ | +9.19% | - | |
0.01% | 112 M€ | +5.31% | - | |
0.00% | 34 M€ | +9.12% | - | |
0.00% | 34 M€ | +4.49% | - | |
0.00% | 39 M€ | +6.43% | - | |
0.00% | 306 M€ | +6.54% | - | |
0.00% | 7 M€ | +0.11% | - | |
0.00% | 17 M€ | +3.40% | - | |
0.00% | 15 M€ | +21.58% | ||
0.00% | 7 M€ | +6.59% | - | |
0.00% | 8 M€ | +1.17% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.35% | 693B | |
+29.39% | 584B | |
-3.49% | 372B | |
+20.15% | 332B | |
+6.19% | 294B | |
+14.11% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+9.21% | 168B |
- Stock Market
- Equities
- 600196 Stock
- 2196 Stock
- Funds and ETFs Shanghai Fosun Pharmaceutical (Group) Co., Ltd.